The purpose of the Reproductive Genetics SIG shall be to establish an organized presence of geneticists, genetic counsellors, and related professionals (reproductive endocrinologists, andrologists, embryologists, ethicists) within the CAFS with the following aims:
- To promote and facilitate translation of knowledge of reproductive genetics to the professionals in the field of human reproduction (natural and assisted) covering but not limited to the areas of female/male
- fertility, embryo genetics, preimplantation/prenatal genetics, genetic screening, genetic testing methods and new techniques, interpretation and impact of genetic results, ethical implications, pharmacogenetics and personalized treatment in reproduction, gene editing and gene therapies.
- To promote the study and discussion of all aspects of the genetics and epigenetics of human reproduction (natural or assisted).
- To establish a system of producing and maintaining evidence-based and ethically sound guidelines for reproductive genetic testing, reporting and counselling.
- To establish and coordinate research, education, and training in preimplantation genetic testing (PGT), and reinforce the collaboration of obstetricians, fertility specialists, embryologists and human geneticists, to insure the implementation of the appropriate PGT technology for the improvement of ART.
- To establish and coordinate research, education, and training in genetic counselling related to reproductive genetics (in coordination with the CAGC Fertility SIG)
- To study the transmission of maternal and paternal genotypes via the gametes and the zygote to the next generation and the way in which this new combination of genetic material expresses itself and is modulated by epigenetic influences.
- To provide a forum for discussion and exchange of information on regulations of gene editing, gene therapy and reproductive genetics in ARTs
- To serve as a resource to health care professions, and the lay public (journalist, politicians) on issues concerning reproductive genetics
- To discuss patient psychosocial issues surrounding genetic testing in ART
Chair - To be announced